Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
31
ANAB Quote, Financials, Valuation and Earnings
Last price:
$22.21
Seasonality move
:
3.83%
Day range:
$21.50 - $22.59
52-week range:
$12.21 - $41.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.83x
P/B ratio:
19.20x
Volume:
683K
Avg. volume:
546.2K
1-year change:
-6%
Market cap:
$653.1M
Revenue:
$91.3M
EPS (TTM):
-$4.85
Earnings Data
Next earnings date for ANAB
Aug 05
2025
Most recent earnings per share
-$1.28
Beat by $0.18
(May 5/2025)
Consensus Estimate
-$1.46
(May 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ANAB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/05/2025 | Q2 | $11.6M | -- | -- | -$1.57 | -- |
| 05/05/2025 | Q1 | $15.3M | $27.8M | -$1.28 | -$1.46 | $0.18 |
| 02/27/2025 | Q4 | $7.8M | $43.1M | -$0.72 | -$1.70 | $0.98 |
| 11/05/2024 | Q3 | $8.2M | $30M | -$1.14 | -$1.61 | $0.47 |
| 08/05/2024 | Q2 | $22.8M | $11M | -$1.71 | -$0.93 | -$0.78 |
| 05/09/2024 | Q1 | $4M | $7.2M | -$1.64 | -$1.60 | -$0.04 |
| 03/11/2024 | Q4 | $3.7M | $9M | -$1.59 | -$1.50 | -$0.10 |
| 11/02/2023 | Q3 | -- | -- | -$1.41 | -$1.89 | $0.48 |
| 08/07/2023 | Q2 | -- | -- | -$1.50 | -$1.74 | $0.24 |
| 05/11/2023 | Q1 | -- | -- | -$1.58 | -$1.02 | -$0.56 |
| 03/01/2023 | Q4 | -- | -- | -$0.93 | -$0.94 | $0.01 |
| 11/08/2022 | Q3 | -- | -- | -$1.18 | -$0.63 | -$0.55 |
| 08/08/2022 | Q2 | -- | -- | -$1.15 | -$1.07 | -$0.08 |
| 05/04/2022 | Q1 | -- | -- | -$1.31 | -$1.01 | -$0.30 |
| 03/07/2022 | Q4 | -- | -- | -$1.18 | $3.99 | -$5.17 |
| 11/04/2021 | Q3 | -- | -- | -$0.24 | -$0.98 | $0.74 |
| 08/09/2021 | Q2 | -- | -- | -$0.02 | -$0.03 | $0.01 |
| 05/04/2021 | Q1 | -- | -- | -$0.66 | -$0.83 | $0.17 |
| 02/25/2021 | Q4 | -- | -- | $1.23 | $0.60 | $0.63 |
| 11/04/2020 | Q3 | -- | -- | -$0.87 | -$0.69 | -$0.18 |
| 08/10/2020 | Q2 | -- | -- | -$0.79 | -$0.65 | -$0.14 |
| 05/06/2020 | Q1 | -- | -- | -$0.30 | -$0.80 | $0.50 |
| 03/02/2020 | Q4 | -- | -- | -$0.75 | -$1.28 | $0.53 |
| 11/08/2019 | Q3 | -- | -- | -$1.15 | -$1.14 | -$0.01 |
| 08/08/2019 | Q2 | -- | -- | -$0.89 | -$0.95 | $0.06 |
| 05/07/2019 | Q1 | -- | -- | -$0.82 | -$0.78 | -$0.04 |
| 02/28/2019 | Q4 | -- | -- | -$0.64 | -$0.86 | $0.22 |
| 11/08/2018 | Q3 | -- | -- | -$0.66 | -$0.70 | $0.04 |
| 08/07/2018 | Q2 | -- | -- | -$0.57 | -$0.67 | $0.10 |
| 05/08/2018 | Q1 | -- | -- | -$0.63 | -$0.46 | -$0.17 |
| 03/05/2018 | Q4 | -- | -- | -$0.30 | -$0.42 | $0.12 |
| 11/07/2017 | Q3 | -- | -- | -$0.45 | -$0.47 | $0.02 |
| 08/10/2017 | Q2 | -- | -- | -$0.13 | -$0.42 | $0.29 |
| 05/11/2017 | Q1 | -- | -- | -$0.75 | -$0.18 | -$0.57 |
AnaptysBio Earnings Questions
-
How Much did AnaptysBio Generate in Revenue Last Quarter?
AnaptysBio reported $27.8M worth of top line sales in its most recent quarter.
-
Did AnaptysBio Beat Earnings Last Quarter?
AnaptysBio announced earnings per share of -$1.28 which represents a beat of analyst forecast a -$1.46 per share.
-
Is AnaptysBio Profitable?
AnaptysBio reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for AnaptysBio EPS Next Year?
AnaptysBio's earnings are forecast to decrease from -$5.12 per share to -$6.18 per share next year representing a decrease of -16.24%.
-
When is AnaptysBio's Earnings Date?
AnaptysBio's next earnings date is August 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
